Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Genomma Lab International SAB DE CV (OTC: GNMLF).

Full DD Report for GNMLF

You must become a subscriber to view this report.


Recent News from (OTC: GNMLF)

Genomma Lab International SAB DE CV reports Q3 results
Genomma Lab International SAB DE CV ( OTCPK:GNMLF ): Q3 Net income of Ps. 213.1M More news on: Genomma Lab International SAB DE CV, Earnings news and commentary, Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: October, 24 2018 17:37
Genomma Lab announces management changes
Genomma Lab Internacional ( OTCPK:GNMLF )  announces that Jorge Luis Brake Valderrama has been named as Chief Executive Officer, effective September 10. More news on: Genomma Lab International SAB DE CV, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 24 2018 08:04
Genomma Lab International SAB DE CV reports Q2 results
Genomma Lab International SAB DE CV ( OTCPK:GNMLF ): Q2 Net income of Ps. 299.1M More news on: Genomma Lab International SAB DE CV, Earnings news and commentary, Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: July, 25 2018 17:33
Genomma Lab International SAB DE CV reports Q1 results
Genomma Lab International SAB DE CV ( OTCPK:GNMLF ): Q1 Net income of Ps.378.6M Revenue of Ps.3.02B (-5.6% Y/Y) Press Release More news on: Genomma Lab International SAB DE CV, Earnings news and commentary, Consumer stocks news,
Source: SeekingAlpha
Date: April, 25 2018 17:09

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.515N/AN/A0
2018-12-13N/A0.515N/AN/A0
2018-12-12N/A0.515N/AN/A0
2018-12-11N/A0.515N/AN/A0
2018-12-10N/A0.515N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-10-18100100100.0000Short
2018-08-231,0001,000100.0000Short
2018-06-051,0001,000100.0000Short
2018-04-2310,20010,200100.0000Short
2017-09-282020100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GNMLF.


About Genomma Lab International SAB DE CV (OTC: GNMLF)

Logo for Genomma Lab International SAB DE CV (OTC: GNMLF)

We are a vast network that includes businesses and institutions that conduct research, manufacture and market pharmaceutical and dermo cosmetic products that meet the highest standards of quality. We are committed to the implementation of national regulations, good manufacturing, documentation and analytical practices.

 

 

 

Current Management

  • Rodrigo Alonso Herrera Aspra / CEO
  • Rodrigo Alonso Herrera Aspra / Chairman

Current Share Structure

  • Market Cap: $1,052,750,000 - 03/16/2018
  • Issue and Outstanding: 1,052,750,000 - 08/05/2013

 



Daily Technical Chart for (OTC: GNMLF)

Daily Technical Chart for (OTC: GNMLF)


Stay tuned for daily updates and more on (OTC: GNMLF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: GNMLF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GNMLF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GNMLF and does not buy, sell, or trade any shares of GNMLF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/